🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › New York › New York City

Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali New York City, NY keessatti

Qorannoo 18 Dhukkubbee Onkoloo Interstishiyali f New York City fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medicine-New York-60569, New York
  • Columbia University Medical Center-New York Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medicine-New York-60569, New York
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Namoota walitti qabaa jiraSadarkaa 2
  • NYU Langone Health, New York
  • Icahn School of Medicine at Mount Sinai, New York
  • Weill Cornell Medicine, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT05798923

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Namoota walitti qabaa jiraSadarkaa 3
  • USA005, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07179380

A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease

Namoota walitti qabaa jiraSadarkaa 2
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Ful-2026 · NCT07323732

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • GSK Investigational Site, New York
  • GSK Investigational Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Namoota walitti qabaa jiraSadarkaa 2
  • Icahn School of Medicine at Mount Sinai, New York
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

Namoota walitti qabaa jira
  • Weill Cornell University Medical College, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT06911632

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Namoota walitti qabaa jiraSadarkaa 3
  • NYU Langone Health, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • New York University Langone Medical Center, New York
  • New York Presbyterian Hospital - Weill Cornell Medicine, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06388421

PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Weill Cornell Medicine, New York
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06855329

Platform Clinical Study for Conquering Scleroderma

Namoota walitti qabaa jiraSadarkaa 2
  • Hospital for Special Surgery, New York
  • Columbia University Medical Center, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

Namoota walitti qabaa jiraSadarkaa 2/3
  • Columbia University Irving Medical Center, New York
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 17-Hag-2026 · NCT06328777

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Weill Medical College of Cornell University, New York
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Namoota walitti qabaa jiraSadarkaa 3
  • Weill Cornell Medicine, New York-Presbyterian Hospital, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05943535

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Namoota walitti qabaa jiraSadarkaa 2
  • aTyr Investigative Site, New York
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2025 · NCT05892614

Qorannoo Dhukkubbee Onkoloo Interstishiyali magaalota biroo keessatti

Qorannoo biroo New York City keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.